In addition to neutralizing antibodies, 2019-nCoV can also induce a cellular immune response, and the levels of 2019-nCoV-specific CD4+ and CD8+ T cells are associated with mild symptoms after infection [17], suggesting the protective role of T cell immunity in 2019-nCoV infection. This evidence concerns the gene CD8A and infection.